SCIENTIFIC HUB

Follow the evidence.

15.306 articles found

Open access

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease.

Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, Taruno Y, Shima A, Fushimi Y, Okada T, Kikuchi T, Morizane A, Hiramatsu S, Anazawa T, Shindo T, Ueno K, Morita S, Arakawa Y, Nakamoto Y, Miyamoto S, Takahashi R, Takahashi J.

Nature · 2025-04-16

DOI: 10.1038/s41586-025-08700-0PMID: 40240591

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Cannabidiol and cognitive functions/inflammatory markers in Parkinson's disease: A double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial).

Mitarnun W, Kanjanarangsichai A, Junlaor P, Kongngern L, Mitarnun W, Pangwong W, Nonghan P.

Parkinsonism Relat Disord · 2025-04-16

DOI: 10.1016/j.parkreldis.2025.107841PMID: 40267585

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.